Bovine Papillomavirus Type 2 (BPV-2) E5 Oncoprotein Binds to the Subunit D of the V1-ATPase Proton Pump in Naturally Occurring Urothelial Tumors of the Urinary Bladder of Cattle
Background Active infection by bovine papillomavirus type 2 (BPV-2) was documented for fifteen urinary bladder tumors in cattle. Two were diagnosed as papillary urothelial neoplasm of low malignant potential (PUNLMP), nine as papillary and four as invasive urothelial cancers. Methods and Findings In all cancer samples, PCR analysis revealed a BPV-2-specific 503 bp DNA fragment. E5 protein, the major oncoprotein of the virus, was shown both by immunoprecipitation and immunohistochemical analysis. E5 was found to bind to the activated (phosphorylated) form of the platelet derived growth factor β receptor. PDGFβR immunoprecipitation from bladder tumor samples and from normal bladder tissue used as control revealed a protein band which was present in the pull-down from bladder cancer samples only. The protein was identified with mass spectrometry as “V1-ATPase subunit D”, a component of the central stalk of the V1-ATPase vacuolar pump. The subunit D was confirmed in this complex by coimmunoprecipitation investigations and it was found to colocalize with the receptor. The subunit D was also shown to be overexpressed by Western blot, RT-PCR and immunofluorescence analyses. Immunoprecipitation and immunofluorescence also revealed that E5 oncoprotein was bound to the subunit D. Conclusion For the first time, a tri-component complex composed of E5/PDGFβR/subunit D has been documented in vivo. Previous in vitro studies have shown that the BPV-2 E5 oncoprotein binds to the proteolipid c ring of the V0-ATPase sector. We suggest that the E5/PDGFβR/subunit D complex may perturb proteostasis, organelle and cytosol homeostasis, which can result in altered protein degradation and in autophagic responses.
References
[1]
Meuten DJ (2002) Tumors of the urinary system. In Meuten, D.J. (Ed) Tumors in Domestic Animals, Blackwell Publishing Company, Iowa State Press, Ames, 524–546.
[2]
？zkul IA, Aydin Y (1996) Tumours of the urinary bladder in cattle and water buffalo in the Black Sea region of Turkey. Br Vet J 152: 473–475. doi: 10.1016/s0007-1935(96)80041-8
[3]
Pamukcu AM, Price JM, Bryan GT (1976) Naturally occurring and bracken fern-induced bovine urinary bladder tumors. Clinical and morphological characteristics. Vet Pathol 13: 110–122.
[4]
Roperto S, Borzacchiello G, Brun R, Leonardi L, Maiolino P, et al. (2010a) A review of bovine urothelial tumours and tumour-like lesions of the urinary bladder. J Comp Pathol 142: 95–108. doi: 10.1016/j.jcpa.2009.08.156
Cairney M, Campo MS (1995) The synergism between bovine papillomavirus type 4 and quercetin is dependent on the timing of exposure. Carcinogenesis 16: 1997–2001. doi: 10.1093/carcin/16.8.1997
[7]
Campo MS (1997) Bovine papillomavirus and cancer. Vet J 154: 175–188. doi: 10.1016/s1090-0233(97)80019-6
[8]
Borzacchiello G, Iovane G, Marcante ML, Poggiali F, Roperto F, et al. (2003) Presence of bovine papillomavirus type 2 and expression of the viral oncoprotein E5 in naturally occurring urinary bladder tumours in cows. J Gen Virol 84: 2921–2926. doi: 10.1099/vir.0.19412-0
[9]
Campo MS, Jarrett WFH, Barron RJ, O’Neil BW, Smith KT (1992) Association of bovine papillomavirus type 2 and bracken fern with bladder cancer in cattle. Cancer Res 52: 6898–6904.
[10]
Roperto S, Brun R, Paolini F, Urraro C, Russo V, et al. (2008) Detection of bovine papillomavirus type 2 (BPV-2) in the peripheral blood of cattle with urinary bladder tumours: possible biological role. J Gen Virol 89: 3027–3033. doi: 10.1099/vir.0.2008/004457-0
[11]
Wosiaki SR, Barreiros MAB, Alfieri AF, Alfieri AA (2005) Semi-nested PCR for detection and typing of bovine papillomavirus type 2 in urinary bladder and whole blood from cattle with enzootic haematuria. J Virol Methods 126: 215–219. doi: 10.1016/j.jviromet.2005.01.021
[12]
Balcos LG, Borzacchiello G, Russo V, Popescu O, Roperto S, et al. (2008) Association of bovine papillomavirus type-2 and urinary bladder tumours in cattle from Romania. Res Vet Sci 85: 145–148. doi: 10.1016/j.rvsc.2007.10.002
[13]
Borzacchiello G, Roperto F (2008) Bovine papillomaviruses, papillomas and cancer in cattle. Vet Res 39: 45–63. doi: 10.1051/vetres:2008022
[14]
Maiolino P, ？zkul A, Sepici-Dincel A, Roperto F, Yücel G, et al. (2013) Bovine papillomavirus type 2 infection and microscopic patterns of urothelial tumors of the urinary bladder in water buffaloes. Biomed Res Int 2013: 937918 doi:10.1155/2013/937918.
[15]
Martano M, Roperto F, de Cassia Stocco R, Russo V, Borzacchiello G (2013) Bovine papillomavirus type 2 (BPV-2) infection and a series of mesenchymal tumors of the urinary bladder in cattle. Biomed Res Int 2013: 814635 doi:10.1155/2013/814635.
[16]
Resendes AR, Roperto S, Trapani F, Urraro C, Rodrigues A, et al. (2011) Association of bovine papillomavirus type 2 (BPV-2) and urinary bladder tumours in cattle from the Azores archipelago. Res Vet Sci 90: 526–529. doi: 10.1016/j.rvsc.2010.02.001
[17]
Roperto S, Comazzi S, Ciusani E, Paolini F, Borzacchiello G, et al. (2011) PBMCs are additional sites of productive infection of bovine papillomavirus type 2. J Gen Virol 92: 1787–1794. doi: 10.1099/vir.0.031740-0
[18]
Roperto S, Russo V, ？zkul A, Sepici-Dincel A, Maiolino P, et al. (2013a) Bovine papillomavirus type 2 infects the urinary bladder of water buffalo (Bubalus bubalis) and plays a crucial role in bubaline urothelial carcinogenesis. J Gen Virol 94: 403–408. doi: 10.1099/vir.0.047662-0
[19]
Shafti-Keramat S, Schellenbacher C, Handisurya A, Christensen N, Reininger B, et al. (2009) Bovine papillomavirus type 1 (BPV1) and BPV2 are closely related serotypes. Virology 393: 1–6. doi: 10.1016/j.virol.2009.07.036
[20]
Conrad M, Bubb VJ, Schlegel R (1993) The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J Virol 67: 6170–6178.
[21]
Borzacchiello G, Russo V, Gentile F, Roperto F, Venuti A, et al. (2006) Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor ？ receptor in naturally occurring bovine urinary bladder tumours. Oncogene 25: 1251–1260. doi: 10.1038/sj.onc.1209152
[22]
Roperto S, De Tullio R, Raso C, Stifanese R, Russo V, et al. (2010b) Calpain 3 is expressed in a proteolitically active form in papillomavirus-associated urothelial tumors of the urinary bladder in cattle. PLoS One 5, e10299.
[23]
Andresson T, Sparkowski J, Goldstein DJ, Schlegel R. (1995) Vacuolar H+ ATPase mutants transform cells and define a binding site for papillomavirus E5 oncoprotein. J Biol Chem 270, 6830–6837.
[24]
Ashrafi GH, Tsirimonaki E, Marchetti BN, O’Brien PM, Sibbet GJ, et al. (2002). Downregulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 21, 248–259.
[25]
Goldstein DJ, Schlegel R (1990) The E5 oncoprotein of bovine papillomavirus binds to a 16 kd cellular protein EMBO J. 9: 137–146.
[26]
Goldstein DJ, Andresson T, Sparkowski JJ, Schlegel R (1992) The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions. EMBO J 11: 4851–4859.
[27]
Roperto S, Russo V, ？zkul A, Corteggio A, Sepici-Dincel A, et al. (2013b) Productive infection of bovine papillomavirus type 2 in the urothelial cells of naturally occurring urinary bladder tumors in cattle and water buffaloes. PLoS One 8: e62227. doi: 10.1371/journal.pone.0062227
[28]
Suprynowicz FA, Campo MS, Schlegel R (2006) Biological activities of papillomavirus E5 proteins. In: Campo, M.S. (Ed.), Papillomavirus Research – from natural history to vaccines and beyond, Caister Academic Press, Norfolk, 97–113.
[29]
Forgac M (2007) Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol 8: 917–929. doi: 10.1038/nrm2272
[30]
Peters LZ, Hazan R, Breker M, Schulcliner M, Ben-Aroya S (2013) Formation and dissociation of proteasome storage granules are regulated by cytosolic pH. J Cell Biol 201: 663–671. doi: 10.1083/jcb.201211146
[31]
Saijo S, Aral S, Hossain KMM, Yamato I, Suzuki K, et al. (2011) Crystal structure of the central axis DF complex of the prokaryotic V-ATPase. Proc Natl Acad Sci 108: 19955–19960. doi: 10.1073/pnas.1108810108
[32]
Romanucci M, Malatesta D, Ciccarelli A, Bongiovanni L, Palmieri C, et al. (2012) Expression of heat shock proteins in premalignant and malignant urothelial lesions of bovine urinary bladder. Cell Stress Chaperones 17: 683–692. doi: 10.1007/s12192-012-0342-6
[33]
Hartl EU, Bracher A, Hayer-Hartl M (2011) Molecular chaperones in protein folding and proteostasis. Nature 475: 324–332. doi: 10.1038/nature10317
[34]
Powers EV, Balch WE (2013) Diversity in the origins of proteostasis networks – a driver for protein function in evolution. Nat Rev Mol Cell Biol 14: 237–248. doi: 10.1038/nrm3542
[35]
Roperto S, Paciello O, Borzacchiello G, Esposito I, Riccardi M, et al. (2013c) Is Bag 3 protein involved in autophagic mechanisms in papillomavirus-associated urothelial tumors in cattle? J Comp Pathol 148: 49. doi: 10.1016/j.jcpa.2012.11.018
[36]
Rapino F, Jung M, Fulda S (2013) BAG3 induction is required to mitigate proteotoxicity via selective autophagy following inhibition of constitutive protein degradation pathways. Oncogene, doi:10.1038/onc.2013.110.
[37]
Ding WX, Ni HM, Gao W, Yoshimori T, Stolz DB, et al. (2007) Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am J Pathol 171: 513–524. doi: 10.2353/ajpath.2007.070188
[38]
Juhász G (2012) Interpretation of bafilomycin, pH neutralizing or protease inhibitor treatments in autophagy flux experiments. Autophagy 12: 1875–1876. doi: 10.4161/auto.21544
[39]
Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850–858. doi: 10.1021/ac950914h
